| Literature DB >> 31370925 |
Fatima Hamouri1, Weiting Zhang1, Isabelle Aujard2, Thomas Le Saux2, Bertrand Ducos1, Sophie Vriz3, Ludovic Jullien2, David Bensimon4.
Abstract
The use of light to control the expression of genes and the activity of proteins is a rapidly expanding field. While many of these approaches use a fusion between a light activatable protein and the protein of interest to control the activity of the latter, it is also possible to control the activity of a protein by uncaging a specific ligand. In that context, controlling the activation of a protein fused to the modified estrogen receptor (ERT) by uncaging its ligand cyclofen-OH has emerged as a generic and versatile method to control the activation of proteins quantitatively, quickly and locally in a live organism. Here, we present the experimental details behind this approach.Entities:
Keywords: Cancer; Development; Optogenetics; Photoactivation
Mesh:
Substances:
Year: 2019 PMID: 31370925 DOI: 10.1016/bs.mie.2019.04.009
Source DB: PubMed Journal: Methods Enzymol ISSN: 0076-6879 Impact factor: 1.600